Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-01
1999-12-21
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 12, A61K 3817
Patent
active
060049367
ABSTRACT:
A method is provided for potentiating the release and collection of cholesterol from inflammatory or atherosclerotic sites in vivo, the method including the steps of increasing the affinity of high-density lipoprotein for macrophages by administering to a patient an effective amount of a composition comprising a compound selected from the group consisting of native serum amyloid A (SAA) and a ligand having SAA properties thereby increasing the affinity of high density lipoprotein (HDL) for macrophages and potentiating release and collection of cholesterol.
REFERENCES:
patent: 5164295 (1992-11-01), Kisilevsky et al.
patent: 5216127 (1993-06-01), Hirai et al.
patent: 5276059 (1994-01-01), Caughey et al.
patent: 5318958 (1994-06-01), Kisilevsky
Kisilevsky, R., "Serum Amyloid A (SAA) Changes HDL's Cellular Affinity: A Clue to SAA's Principal Function", Annual Meeting Abstracts, Abstract No. 633, p. 107A. (Jan. 1992).
Tape, C., et al.; "Direct Evidence for Circulating apoSAA as the Precursor of Tissue AA Amyloid Deposits", Scand. J. Immunol., vol. 28, pp. 317-324 (1988).
Agnani, G. et al., (1993), "Cholesterol Efflux from Fibroblasts to Discoidal Lipoproteins with Apolipoprotein A-I (LpA-I) Increases with Particle Size but Cholesterol Transfer from LpA-I to Lipoproteins Decreases with Size", Biochem. 32:2643-2649.
Basu, S.K. et al., (1982), "Biochemical and Genetic Studies of the Apoprotein E Secreted by Mouse Macrophages and Human Monocytes", J. Biol. Chem. 257(16):9788-9795.
Brewer et al., (1986) Meth. Enzymol. 128:223-247.
Brissette et al., (1989) "Differential Induction of the Serum Amyloid-A Gene Family . . . ", J. Biol. Chem. 264:19327.
DeLamatre, J., et al., (1986), "Role of apolipoproteins in cellular cholesterol efflux", Biochim. et Biophys. Acta 875:419-428.
Dory, L., (1991), "Regulation of apolipoprotein E secretion by high density lipoprotein.sub.3 in mouse macrophages", J. Lipid Res. 32:783-792.
Fidge, N.H. et al., (1985), "Identification of Apolipoproteins Involved in the Interaction of Human High Density Lipoprotein.sub.3 with Receptors on Cultured Cells", J. Biol. Chem. 260(6):3750-3575.
Ganapathi, M.K. et al., (1988), "Heterogenous Nature of the Acute Phase Response: Differential Regulation of Human Serum Amyloid A, C-Reactive Protein, and Other Acute Phase Proteins by Cytokines in Hep 3B Cells", J. Immunol. 141(2):564-569.
Glomset, J.A., (1968), "The plasma lecithin: cholesterol acyltransferase reaction", J. Lipid Res. 9:155-167.
Gomori, G. et al., 1942, "A Modification of the Colorimetric Phosphorus Determination for Use with the Photoelectric Colorimeter", J. Lab. Clin. Med. 27:955-960.
Hara, H., et al., (1991), "Interaction of Free Apolipoproteins with Macrophages: Formation of High Density Lipoprotein-Like Lipoproteins and Reduction of Cellular Cholesterol", J. Biol. Chem. 266(5):3080-3086.
Hoffman, J.S. et al., (1982), "Changes in High Density Lipoprotein Content Following Endotoxin Administration in the Mouse: Formation of Serum Amyloid Protein-Rich Subfractions", J. Biol. Chem. 257(17):10510-10517.
Hoffman, J.S. et al., (1982), "Secretion of Serum Amyloid Protein and Assembly of Serum Amyloid Protein-rich High Density Lipoprotein in Primary Mouse Hepatocyte Culture", J. Biol. Chem. 257(17):10518-10522.
Hoffman, J.S. et al., (1984), "Murine Tissue Amyloid Protein AA NH.sub.2 -Terminal Sequence Identity with Only One of Two Serum Amyloid Protein (ApoSAA) Gene Products", J. Exp. Med. 159:641-646.
Husebekk et al., (1987), "Characterization of Amyloid Proteins AA and SAA . . . " Scand. J. Immunol. 25:375-381.
Jonas, A., (1986), "Reconstitution of High-Density Lipoproteins", Methods In Enzymology 128:553-582.
Kisilevsky, R. (1991), "Serum Amyloid A (SAA), a Protein without a function . . . "Med. Hypotheses 35:337-341.
Kisilevsky, R. et al., (1977), "The Role of Inflammatory Cells in the Pathogenesis of Amyloidosis", Lab. Invest. 37(6):544-553.
Kisilevsky, R. et al., (1992), "Serum Amyloid A Changes High Density Lipoprotein's Cellular Affinity", Lab. Invest. 66(6):778-785.
Liang, J. et al., (1995), "Recombinant human serum amyloid A (apoSAA.sub.p) binds cholesterol and modulates cholesterol flux", J. Lipid Res., 36:37-46.
Lowell, C.A. et al., (1986), "Structure of the Murine Serum Amyloid A Gene Family", J. Biol. Chem. 261(19):8442-8452.
Lowry et al., (1951), "Measurement with the Folin Phenol Reagent", J. Biol. Chem. 193:265.
Mahley, R.W., (1988), "Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology", Science 240:622-630.
Miura et al., (1990), "Intraperitoneal Amylod Formation by Amyloid . . . ", in Amyloid and Amyloidosis, p. 523 (Dordrecht, Klumer Academic Publishers).
Narindrasorasak et al., (1991), "High Affinity Interactions between the Alzheimer's . . . ", J. Biol. Chem. 266:12878.
Parmelee, D.C. et al. (1982), "Amino Acid Sequence of Amyloid-Related Apoprotein (apoSAA.sub.1) from Human High-Density Lipoprotein", J. Biochem. 21(14):3298-3302.
Schmitz et al., (1985), "Interaction of High Density Lipoproteins with Cholesteryl Ester Laden Macrophages . . . " EMBO J. 4:613-622.
Schumaker et al., (1986) "Sequential Flotation Ultracentrifugation", Math. Enzymol. 128:155-170.
Selinger, M.J. et al., (1980), "Monokine-induced synthesis of serum amyloid A protein by hepatocytes", Nature 285:498-500.
Steinmetz et al., (1989), "Influence of Serum Amyloid-A on Cholesterol . . . " Biochem, Biophys. Acta. 1006:173.
Subrahmanyan et al., (1988), "Effects of Culture Substrates and Normal . . . " Scand J. Immul. 27:251.
van der Westhuyzen et al., "Serum Amyloid A Protein Plasma . . . " in Amyloidosis, p. 115 (Martinus, Nijhoff, Dordrecht), Section IV, Chapter 3, 1986.
Westermark, G., et al., (1992) "The N-Terminal Segment of Protein AA Determines Its Fibrillogenic Property," Biochem. and Biophys. Res. Comm., 182:1:27-33.
Kisilevsky, R., "Serum Amyloid A Influences The Efflux Of Cholesterol From Macrophages", Amyloid and Amyloidosis 1993, The Proceedings of the VIIth International Symposium on Amyloidosis, Jul. 11-15, 1993, Kingston, Ontario, Canada, pp. 115-118.
Queen's University at Kingston
Sayala Chhaya D.
Steeg Carol Miernicki
LandOfFree
Method of use of serum amyloid a protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of use of serum amyloid a protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of use of serum amyloid a protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505152